Top Stories News

With growing awareness for sustainable industry practices within pharmaceuticals, pharma packaging companies are facing pressures to balance drug efficacy, patient safety, supply chain security, and sustainability. Speakers Sriman Banerjee, Head of Pac...

As we continue to celebrate the contributions of women in the pharmaceutical field following International Day of Women and Girls in Science and in the lead up to International Women’s Day on March 8, 2023, we take a look at some of the historic ...

Three reasons why advancing gender equity in healthcare should be a priority for pharma 

An increasing number of drug development pipelines are turning towards the use of HPAPIs to target rare and ‘undruggable’ diseases. In this article, we talk to leading industry experts about how pharmaceutical manufacturers are adapting and...

The Switzerland-based pharmaceutical process and ingredient developer and manufacturer announced the opening of their new sterile liquid drug product manufacturing facility in France.

An expansion of Pfizer’s not-for-profit health equity program will offer up to 500 patented and off-patent products to 45 lower-income countries, building on their initial offering of patented medicines and vaccines in the US and EU.

A USD $42 million collaboration between AbbVie and Anima Biotech aims to leverage the latter’s mRNA Lightning technology platform to enhance therapeutic development programs in oncology and immunology.

Machine-learning models demonstrate the potential to accelerate drug formulation discovery and development for long-acting injectables.

Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio.

In the US, retail pharmacies will be allowed to sell abortion pills for the first time, after latest approval is granted by the FDA. 

Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January.

Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain.

In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar...

A comprehensive, long-term partnership agreement between AstraZeneca and G42 Healthcare is set to enhance local drug manufacturing in Abu Dhabi, UAE, and bolster pharmaceutical manufacturing innovation within the country.

Download our Trend Report to discover what the current landscape of APIs and their pricing means for the pharmaceutical industry in the future.

A monoclonal antibody drug, named lecanemab, has been tested in a Phase III clinical trial in nearly 1800 participants, with promising results in reducing the effects of Alzheimer's disease on the brain. 

In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h...

South African biopharma company Biovac signs a partnership deal with the International Vaccine Institute to develop and manufacture an oral cholera vaccine for both the African and global market. 

A new method of vaccine technology that employs weakened viruses has been developed to target DNA viruses that reproduce by making copies of their own DNA molecules, utilising a virus with altered DNA to fight against them.

In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We chatted to Marco Chiadò Piat (President) and Anil Busimi (VP Strategy and Marketing)...

Sandoz, a leader in generic pharmaceutical and biosimilars, have announced their intentions to invest EUR €50 million in support of a technology upgrades at their Austrian manufacturing site to support increasing penicillin demands. 

GSK has released a statement on the failure of Blenrep in achieving the main goals of a late-stage study for the blood cancer therapeutic, raising concerns of regulatory approval being rescinded.

Latest newsletter from Axplora - API manufacturer

Aragen is set to open their new manufacturing facility at their Mallapur campus in Hyderabad, India in January 2023, enhancing the company’s ability to provide scaled manufacturing solutions and clinical supplies to their customers.

Scitara and Veeva have announced a partnership to bring improved data infrastructures to the quality control process of drug and therapeutic market release.

The major expansion of Quotient Sciences’ drug substance manufacturing facility in Alnwick has been completed, promising increased manufacturing systems and capabilities. 

South Korean chemical company LG Chem is set to acquire AVEO Oncology, an oncology-focused biopharmaceutical company based in the USA, as part of an investment to increase its footprint in North America and expand its development and commercialisation ...

Purolite, an Ecolab company, marked the opening of a new Customer Experience Centre featuring hands-on interactive and educational displays, showcasing the company’s expanded bioprocessing solutions.

Evonik will be provided with sterile solutions from a collaboration between ChargePoint Technology Group and STERIS, utilising ChargePoint’s AseptiSafe Bio Valve and STERIS’ bio-decontamination systems.

BioNTech, co-developers of one of the first mRNA COVID-19 vaccines, have signed an agreement to create manufacturing hubs in and around the Australian Victoria state in a bid to increase the country’s mRNA manufacturing abilities.

In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm...

Provention Bio, Inc. have granted exclusive right of first negotiation to Sanofi in exchange for commercial resources in the United States for the potential approval and launch of monoclonal antibody therapeutic teplizumab.

Crest Cellulose, an Indian excipient manufacturer, has been acquired by plant-based pharmaceutical excipient provider Roquette in a bid to increase the latter’s presence in the Asia Pacific region.

The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility.

With the rapid development and manufacturing of new drugs and therapeutics being pushed through the pipeline, excipient manufacturers are navigating a challenging landscape to meet the demand for new and novel excipients.  

Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access.

Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. 

‘Poxy McPoxface’, ‘TRUMP-22’, and ‘Mpox’ are just some of the suggestions submitted by the public  

China’s pharmaceutical industry is changing from formerly generics-focused into one that emphasizes innovation, spurred by shifting government policy and an aging population.

As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August.   

A look at the companies extracting valuable insights from health data to accelerate clinical development and support regulatory decision making. 

GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site.

The latest episode in the CPHI Podcast Series dives into the world of novel excipients and explores their importance for innovative drug development. 

Researchers develop method to produce organoid materials for disease and drug development research.

Serious concerns have been raised about the quality of landmark Alzheimer’s research, undermining commonly held beliefs about the disease

Nine members of the WHO’s expert committee voted against the designation, while six voted in favour

Monkeypox is unlikely to develop into another pandemic, according to the WHO. But the recent spread of the virus could still be a challenge for the vaccine industry. 

Fred Hutchinson is sponsoring the Phase 1 trial, while Amazon are contributing scientific and machine learning expertise

The latest instalment in the CPHI Podcast Series dives into the world of supplements and explores the impact of COVID-19 on this booming market  

In The Future of Outsourcing - Strategies for Partner Selection, experts from across the pharma industry look at current trends impacting the contract services landscape and gauge the merits and drawbacks of the most common outsourcing strategies ...

Several countries are stepping up vaccination and testing as monkeypox cases continue to climb

Companies that are further down the road to market are more attractive to investors than those in early development 

The new facility is set to quadruple the company's HQ plasmid DNA capacity 

The UN agency convened a meeting last week to discuss the outbreak 

A US-based biotech is seeking damages for Pfizer’s use of a patented coronavirus 3CL protease inhibitor in its blockbuster drug Paxlovid  

VLA15 is the only Lyme disease vaccine candidate currently in clinical development 

The vaccines have been adapted to target the Omicron variant, which has been the dominant variant globally since the beginning of the year 

A committee will meet next week to discuss issuing the emergency designation.

The Rwanda site will be the first piece of the company’s African manufacturing network  

Smaller companies targeting rare and extremely specific treatment areas are leading the charge in this emerging market.  

CordenPharma, a full-service CDMO of APIs, Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy. 

Through the entire product lifecycle – production, consumption and disposal – the pharma industry significantly impacts the environment.  

Engagement-based strategy could increase resilience of pharma supply chain. 

Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. 

Robust oversight linked to increased efficiency and better communication with outsourcing partners. 

The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. 

We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. 

Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. 

Informa Markets colleagues explain the motivations behind CPHI’s rebrand. 

Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction.   

The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes. 

The first COVID-19 vaccine plant in Africa is at risk of closure due to lack of demand. 

For a full rundown on tech trends driving the sector, catch these five sessions at Pharmapack 2022 

Supply chain disruptions have become the new normal. Recurring pandemic waves, inflation, trade jitters and a war in Europe have done little to quell C-suite anxieties.  

The contract development and manufacturing organisation (CDMO) has completed the first phase of its multi-million-pound development. 

The war in Ukraine has forced companies to suspend or delay clinical trials in the region.

Pharmapack 2022 is just around the corner and judging for its annual awards is already underway. Every year a jury of industry experts assesses a range of products making waves in packaging and drug delivery and ultimately crowns a handful of winners a...

Global mergers and acquisitions hit an all-time high in 2021, and in the life sciences industry these kinds of deals show no sign of slowing down. 

Smart devices are revolutionising how we live our lives and changing the shape of the industries adopting them. One such industry is healthcare, where the benefits of context-aware devices and real-time data sharing are having tangible effects on patie...

Moderna announces up to USD $500 million investment for the construction of mRNA vaccine manufacturing facility in Kenya, the first of its kind on the African continent. The facility will be a significant step towards vaccine equity...

In this month's edition of the CPHI Webinar Series, experts from BioPlan Associates and NIBRT share insights on key trends impacting the biomanufacturing and bioprocessing sector.

Contract development and manufacturing organisation Micro-Sphere has invested more than €1.5 million at its plant in Switzerland to expand its offering in encapsulation for inhalation products.

The biopharmaceutical industry has seen incredible growth in the past decade, and shows no sign of slowing as the need for specialised treatments in oncology, immunology and vaccines continue to grow.

By joining forces, the two companies will be able to bring Dispersome to the market faster for novel drug development

The biopharma industry drives development of complex therapies which improve the health outcomes and quality of life of patients across the globe. It is however a significant contributor to environmental waste and emissions as a direct result of it'...

A diverse range of sectors and industries come together in partnership to address infection management, advocating a whole system approach

COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.

Samsung Biologics has reached an agreement for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion.

The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.

Lagevrio and Paxlovid are the only COVID-19 pills cleared for emergency use at present, but others are coming with developers racing to bring oral antivirals to this potentially lucrative market.

We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event.

CDMO currently manufacturing LAAB combination treatment  and will start on cancer immunotherapy product from next year

CPHI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPHI Online.

The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges

It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness.

The offering will accelerate timelines for the development and manufacturing of molecules and disruptive technologies

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

In this special edition podcast, Informa Markets pharma editor Gareth Carpenter speaks to Bikash Chatterjee, CEO at Pharmatech Associates and Dan Stanton, Editor and Founder at BioProcess International about some of the findings in the recently pu...

The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business

China is the pharma industry’s biggest gainer in the 2021 CPHI Annual Rankings, with digital matchmaking driving new waves of partnerships

CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

The proposed state-of-the-art facility could potentially produce up to 100 million vaccine doses each year for Australians

Awards seek to recognise ‘Excellence in Pharma’, assessing entries from the industry’s leading companies and individuals.

The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPHI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market

The concept of patient centricity has many nuances, and designing dosage forms needs to be underpinned by a multi-functional perspective utilised as early as possible, say experts

Rather than looking back at what has been a challenging past few months, this Trend Report - featuring highlights from the Pharmapack 2021 content programme - has been written very much in the spirit of looking forward and addressing the key challenges...

Rise of innovative companies with high-risk portfolios will necessitate need for CDMOs, says Thermo Fisher senior executive

COVID-19 pandemic has exposed weaknesses and sector faces new challenges driven by rising costs of production in China

Current EU regulatory systems too overwhelmed by paper, head of European association representing generics, biosimilars and value added medicines industries tells CPHI Worldwide online conference

Country expected to grow threefold over the next decade due to increased focus on complex generics, biosimilars and specialty products

According to unnamed sources in Politico report, company’s vaccine batches have not met FDA purity level standards

UCB Pharma is informed by agency that action on application for psoriasis treatment is being deferred until on-site visits can be made

Manufacturer starts development of API for molnupiravir, which is set to become world’s first oral treatment against coronavirus

Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories

Panel discusses how healthcare institutions are adapting to calls for more sustainability in various processes in the value chain

Pre-filled syringes (PFS) could help immensely in solving the challenges of rolling out future mass vaccination campaigns, according to experts at Becton Dickinson (BD).

During the live Innovation in Connectivity Roundtable at the Pharmapack 2021 online conference, experts discussed how the latest innovations in digital technology are shaping industry ambitions to put the patient journey at the heart of its drug device...

The LSCC provides an additional 30% in mammalian large-scale capacity for the company's own pipeline and for third parties

Just as 'food miles' have become a key concern among consumers in recent years, patients now want to know more about 'medicine miles', study commissioned by Teva finds

Electronic devices and connectivity are being progressively included in drug delivery devices, bringing positive outcomes to all stakeholders, according to drug device combinations specialist, Nemera Tuesday